CYTOKINE IMBALANCE AS ONE OF PROGNOSTIC CRITERIA FOR DISSEMINATED SCLEROSIS COURSE
Abstract
Summary - The fact that the disseminated sclerosis belongs to autoimmune
diseases predominates dependence of its progression rate
on the cytokine imbalance. The authors study levels of relation between
pro-inflammatory and anti-inflammatory cytokines during
aggravation of the disease and in remission in 19 patients aged 20
to 58 with various types of the disseminated sclerosis course. As
reported, disseminated sclerosis is characterised by considerable
increase in 1 and 6 interleukin concentrations. It reaches its maximum
values during aggravation under low levels of interleukin-1
receptor antagonist and tumour necrosis factor-. There is a dependence
of these indices on the disease stage. The prognostic criteria
for disseminated sclerosis are interleukin-1/nterleukin-1 receptor
antagonist and tumour necrosis factor- concentration
diseases predominates dependence of its progression rate
on the cytokine imbalance. The authors study levels of relation between
pro-inflammatory and anti-inflammatory cytokines during
aggravation of the disease and in remission in 19 patients aged 20
to 58 with various types of the disseminated sclerosis course. As
reported, disseminated sclerosis is characterised by considerable
increase in 1 and 6 interleukin concentrations. It reaches its maximum
values during aggravation under low levels of interleukin-1
receptor antagonist and tumour necrosis factor-. There is a dependence
of these indices on the disease stage. The prognostic criteria
for disseminated sclerosis are interleukin-1/nterleukin-1 receptor
antagonist and tumour necrosis factor- concentration
About the Authors
С. Гуляева
Владивостокский государственный медицинский университет
Russian Federation
Russian Federation
Л. Иванушко
НИИ эпидемиологии и микробиологии СО РАМН
Russian Federation
Russian Federation
А. Овчинников
Владивостокский государственный медицинский университет
Russian Federation
Russian Federation
Н. Беседнова
Владивостокский государственный медицинский университет
Russian Federation
Russian Federation
М. Короткова
Владивостокский государственный медицинский университет
Russian Federation
Russian Federation
В. Шаркова
Владивостокский государственный медицинский университет
Russian Federation
Russian Federation
О. Фомина
Владивостокский государственный медицинский университет
Russian Federation
Russian Federation
А. Овчинникова
Владивостокский государственный медицинский университет
Russian Federation
Russian Federation
S. E. Gulyaeva
Vladivostok State Medical University
Russian Federation
Russian Federation
L. A. Ivanushko
Research Institute of Epidemiology and
Microbiology, Siberian Branch of RAMS
Russian Federation
Russian Federation
A. V. Ovchinnikova
Vladivostok State Medical University
Russian Federation
Russian Federation
N. A. Besednova
Vladivostok State Medical University
Russian Federation
Russian Federation
M. A. Korotkova
Vladivostok State Medical University
Russian Federation
Russian Federation
V. A. Sharkova
Vladivostok State Medical University
Russian Federation
Russian Federation
O. I. Fomina
Vladivostok State Medical University
Russian Federation
Russian Federation
A. A. Ovchinnikova
Vladivostok State Medical University
Russian Federation
Russian Federation
References
1. Гусев Е.И., Демина Т.Л., Бойко А. Н. Рассеянный склероз. М.: Нефть и газ, 1997. 463 с.
2. Рассеянный склероз. Избранные вопросы теории и практики / под ред. И.А. Завалишина, В.И. Головкина. М.: ЭльфИПР, 2000. 640 с.
3. Hohlfeld R. Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives [Invited review] // Brain. 1997. Vol. 120. P. 865-916.
4. Kornek B., Storch M., Bauer J. et al. Distribution of calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis // Brain. 2001. Vol. 124. P. 1114-1124.
5. Lucchinetti C., Brueck W., Rodriguez M., Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis // Brain Pathol. 1996. Vol. 6. P. 259-274.
6. Rieckmann P., Maurer M. Anti-inflammatory strategies to prevent axonal injury in multiple sclerosis // Curr. Opin. Neurol. 2002. Vol. 15. P. 361-370.
7. Smith K.J., Hall S.M. Factors directly affecting impulse transmission in inflammatory demyelinating disease: recent advances in our understanding // Curr. Opin. Neurol. 2001. Vol. 14. P. 289-298.
8. Trapp B.D., Ransohoff R.M., Fisher E., Rudick R.A. Neurodegeneration in multiple sclerosis: relationship to neurological disability // Neurosci. 1999. Vol. 5. P. 48-57.
9. Waxman S.G. Loss and restoration of impulse conduction in disorders of myelin // Handbook of multiple sclerosis / ed. S. D. Cook. Marcel Dekker Inc., 2001. P. 257-288.
10. Waxman S.D. Transcriptional channelopathies: an emerging class of disorders // Neurosci. 2001. Vol. 2. P. 652-659 .
Review
For citations:
, , , , , , , , Gulyaeva S.E., Ivanushko L.A., Ovchinnikova A.V., Besednova N.A., Korotkova M.A., Sharkova V.A., Fomina O.I., Ovchinnikova A.A. CYTOKINE IMBALANCE AS ONE OF PROGNOSTIC CRITERIA FOR DISSEMINATED SCLEROSIS COURSE. Pacific Medical Journal. 2010;(4):55-58. (In Russ.)
Views:
261
Email this article 